Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O N Witte

Showing results (101-110 of 211) with videos related to

Pageof 22
Sort By:
Advances in Immunology|May 29, 2016
Advances in PET Detection of the Antitumor T Cell ResponseM N McCracken, R Tavaré, O N Witte, et al.
Cell|July 1, 1982
In vivo tyrosine phosphorylations of the Abelson virus transforming protein are absent in its normal cellular homologA S Ponticelli, C A Whitlock, N Rosenberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1978
Vesicular stomatitis virus glycoprotein is necessary for H-2-restricted lysis of infected cells by cytotoxic T lymphocytesA H Hale, O N Witte, D Baltimore, et al.
Cancer Metastasis Reviews|June 16, 2000
Target antigens for prostate cancer immunotherapyD C Saffran, R E Reiter, A Jakobovits, et al.
Oncogene|August 1, 1991
The 5' non-coding region of the BCR/ABL oncogene augments its ability to stimulate the growth of immature lymphoid cellsM L Gishizky, J McLaughlin, A M Pendergast, et al.
Molecular and Cellular Biology|September 1, 1991
Differences in oncogenic potency but not target cell specificity distinguish the two forms of the BCR/ABL oncogeneM Kelliher, A Knott, J McLaughlin, et al.
Science (New York, N.Y.)|March 2, 1990
Tyrosine kinase activity and transformation potency of bcr-abl oncogene productsT G Lugo, A M Pendergast, A J Muller, et al.
Journal of Virology|February 1, 1986
Monoclonal antibody to the amino-terminal L sequence of murine leukemia virus glycosylated gag polyproteins demonstrates their unusual orientation in the cell membraneE A Pillemer, D A Kooistra, O N Witte, et al.
Current Topics in Microbiology and Immunology|January 1, 1986
An in vitro model for tumor progression in murine lymphoid cellsR C Schwartz, L W Stanton, K B Marcu, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 12, 2000
BCR/ABL inhibition by an escort/phosphatase fusion proteinY M Lim, S Wong, G Lau, et al.
Pageof 22

Showing results (101-110 of 211) with videos related to

Sort By:
Pageof 22
Advances in Immunology|May 29, 2016
Advances in PET Detection of the Antitumor T Cell ResponseM N McCracken, R Tavaré, O N Witte, et al.
Cell|July 1, 1982
In vivo tyrosine phosphorylations of the Abelson virus transforming protein are absent in its normal cellular homologA S Ponticelli, C A Whitlock, N Rosenberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1978
Vesicular stomatitis virus glycoprotein is necessary for H-2-restricted lysis of infected cells by cytotoxic T lymphocytesA H Hale, O N Witte, D Baltimore, et al.
Cancer Metastasis Reviews|June 16, 2000
Target antigens for prostate cancer immunotherapyD C Saffran, R E Reiter, A Jakobovits, et al.
Oncogene|August 1, 1991
The 5' non-coding region of the BCR/ABL oncogene augments its ability to stimulate the growth of immature lymphoid cellsM L Gishizky, J McLaughlin, A M Pendergast, et al.
Molecular and Cellular Biology|September 1, 1991
Differences in oncogenic potency but not target cell specificity distinguish the two forms of the BCR/ABL oncogeneM Kelliher, A Knott, J McLaughlin, et al.
Science (New York, N.Y.)|March 2, 1990
Tyrosine kinase activity and transformation potency of bcr-abl oncogene productsT G Lugo, A M Pendergast, A J Muller, et al.
Journal of Virology|February 1, 1986
Monoclonal antibody to the amino-terminal L sequence of murine leukemia virus glycosylated gag polyproteins demonstrates their unusual orientation in the cell membraneE A Pillemer, D A Kooistra, O N Witte, et al.
Current Topics in Microbiology and Immunology|January 1, 1986
An in vitro model for tumor progression in murine lymphoid cellsR C Schwartz, L W Stanton, K B Marcu, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 12, 2000
BCR/ABL inhibition by an escort/phosphatase fusion proteinY M Lim, S Wong, G Lau, et al.
Pageof 22